TWIST1 and neoplasm: Twist1 deficiency in ECs substantially improved the survival of tumor-bearing mice; more than half of Twist1 knockout mice were alive at days 28 and 23 post-tumor induction in GL261 and RCAS models, respectively, compared to the control group, where all the mice died (Fig. 3, B and C).